FRA
Front Row Advisors’s Tandem Diabetes Care TNDM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86K | Hold |
100
| – | – | ﹤0.01% | 470 |
|
|
2025
Q1 | $1.92K | Hold |
100
| – | – | ﹤0.01% | 449 |
|
|
2024
Q4 | $3.6K | Hold |
100
| – | – | ﹤0.01% | 422 |
|
|
2024
Q3 | $4.24K | Sell |
100
-188
| -65% | -$7.97K | ﹤0.01% | 416 |
|
|
2024
Q2 | $11.6K | Sell |
288
-27
| -9% | -$1.09K | ﹤0.01% | 537 |
|
|
2024
Q1 | $11.2K | Buy |
315
+215
| +215% | +$7.61K | ﹤0.01% | 556 |
|
|
2023
Q4 | $2.96K | Hold |
100
| – | – | ﹤0.01% | 397 |
|
|
2023
Q3 | $2.08K | Hold |
100
| – | – | ﹤0.01% | 812 |
|
|
2023
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 825 |
|
|
2023
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 736 |
|
|
2022
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 702 |
|
|
2022
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 665 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 642 |
|
|
2022
Q1 | $12K | Hold |
100
| – | – | ﹤0.01% | 526 |
|
|
2021
Q4 | $15K | Hold |
100
| – | – | 0.01% | 485 |
|
|
2021
Q3 | $12K | Hold |
100
| – | – | 0.01% | 522 |
|
|
2021
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 549 |
|
|
2021
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 579 |
|
|
2020
Q4 | $10K | Hold |
100
| – | – | 0.01% | 531 |
|
|
2020
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 546 |
|
|
2020
Q2 | $10K | Hold |
100
| – | – | 0.01% | 477 |
|
|
2020
Q1 | $8K | Hold |
100
| – | – | 0.01% | 522 |
|
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 591 |
|
|
2019
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 567 |
|
|
2019
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 558 |
|
|
2019
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 551 |
|
|
2018
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 615 |
|
|
2018
Q3 | $3 | Buy |
+100
| New | +$3 | ﹤0.01% | 733 |
|